Cell Therapy for Neurological Disorders: The Perspective of Promising Cells

被引:11
作者
Liu, Donghui [1 ]
Bobrovskaya, Larisa [1 ]
Zhou, Xin-Fu [1 ]
机构
[1] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA 5000, Australia
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 11期
关键词
cell therapy; cell transplantation; neurological disorders; stem cells; clinical trials; MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; HUMAN UMBILICAL-CORD; OLFACTORY ENSHEATHING CELLS; FUNCTIONAL RECOVERY; ISCHEMIC-STROKE; MULTIPLE-SCLEROSIS; NEURAL PROGENITORS; TERATOMA FORMATION; CONDITIONED MEDIUM;
D O I
10.3390/biology10111142
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple SummaryCell therapy has become a powerful method for regenerative medicine. However, there has not been an ideal cell type and cell source for the treatment of neurological diseases such as Parkinson's disease and Alzheimer's disease. This review aims to introduce the potentials of different cells for treating neurological disorders by collecting the results from related clinical trials and recent animal studies. It is an overview of some promising cells that may be clinically used for neurological disorders. The characteristics of each cell type and the main mechanism of function are also described.Neurological disorders are big public health challenges that are afflicting hundreds of millions of people around the world. Although many conventional pharmacological therapies have been tested in patients, their therapeutic efficacies to alleviate their symptoms and slow down the course of the diseases are usually limited. Cell therapy has attracted the interest of many researchers in the last several decades and has brought new hope for treating neurological disorders. Moreover, numerous studies have shown promising results. However, none of the studies has led to a promising therapy for patients with neurological disorders, despite the ongoing and completed clinical trials. There are many factors that may affect the outcome of cell therapy for neurological disorders due to the complexity of the nervous system, especially cell types for transplantation and the specific disease for treatment. This paper provides a review of the various cell types from humans that may be clinically used for neurological disorders, based on their characteristics and current progress in related studies.
引用
收藏
页数:23
相关论文
共 189 条
[1]   Improvement of Rat Spinal Cord Injury Following Lentiviral Vector-Transduced Neural Stem/Progenitor Cells Derived from Human Epileptic Brain Tissue Transplantation with a Self-assembling Peptide Scaffold [J].
Abdolahi, Sara ;
Aligholi, Hadi ;
Khodakaram-Tafti, Azizollah ;
Khaleghi Ghadiri, Maryam ;
Stummer, Walter ;
Gorji, Ali .
MOLECULAR NEUROBIOLOGY, 2021, 58 (06) :2481-2493
[2]   Pre-differentiation of human neural stem cells into GABAergic neurons prior to transplant results in greater repopulation of the damaged brain and accelerates functional recovery after transient ischemic stroke [J].
Abeysinghe, Hima C. S. ;
Bokhari, Laita ;
Quigley, Anita ;
Choolani, Mahesh ;
Chan, Jerry ;
Dusting, Gregory J. ;
Crook, Jeremy M. ;
Kobayashi, Nao R. ;
Roulston, Carli L. .
STEM CELL RESEARCH & THERAPY, 2015, 6
[3]   Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson's disease [J].
Acquarone, Mariana ;
de Melo, Thiago M. ;
Meireles, Fernanda ;
Brito-Moreiras, Jordano ;
Oliveira, Gabriel ;
Ferreira, Sergio T. ;
Castro, Newton G. ;
Tovar-Moil, Fernanda ;
Houzel, Jean-Christophe ;
Rehen, Stevens K. .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9 :1-12
[4]   Mesenchymal stem cells transplantation attenuates brain injury and enhances bacterial clearance in Escherichia coli meningitis in newborn rats [J].
Ahn, So Yoon ;
Chang, Yun Sil ;
Kim, Young Eun ;
Sung, Se In ;
Sung, Don Kyung ;
Park, Won Soon .
PEDIATRIC RESEARCH, 2018, 84 (05) :778-785
[5]   Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia [J].
Albert, Katrina ;
Niskanen, Jonna ;
Kalvala, Sara ;
Lehtonen, Sarka .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
[6]   An efficient method for generation of neural-like cells from adult human bone marrow-derived mesenchymal stem cells [J].
Alexanian, Arshak R. .
REGENERATIVE MEDICINE, 2010, 5 (06) :891-900
[7]   Evaluation of Dental Pulp Stem Cell Heterogeneity and Behaviour in 3D Type I Collagen Gels [J].
Alraies, Amr ;
Waddington, Rachel J. ;
Sloan, Alastair J. ;
Moseley, Ryan .
BIOMED RESEARCH INTERNATIONAL, 2020, 2020
[8]  
Augustyniak J, 2014, ACTA NEUROBIOL EXP, V74, P373, DOI 10.55782/ane-2014-2000
[9]   Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma [J].
Bago, Juli R. ;
Alfonso-Pecchio, Adolfo ;
Okolie, Onyi ;
Dumitru, Raluca ;
Rinkenbaugh, Amanda ;
Baldwin, Albert S. ;
Miller, C. Ryan ;
Magness, Scott T. ;
Hingtgen, Shawn D. .
NATURE COMMUNICATIONS, 2016, 7
[10]   Grafted human induced pluripotent stem cells improve the outcome of spinal cord injury: modulation of the lesion microenvironment [J].
Bellak, Tamas ;
Fekecs, Zoltan ;
Torok, Denes ;
Tancos, Zsuzsanna ;
Nemes, Csilla ;
Tezsla, Zsofia ;
Gal, Laszlo ;
Polgari, Suchitra ;
Kobolak, Julianna ;
Dinnyes, Andras ;
Nogradi, Antal ;
Pajer, Krisztian .
SCIENTIFIC REPORTS, 2020, 10 (01)